Chief Executive Officer @ T2cure (January 2007 - July 2010)
Consultant @ Mr Biotech (January 2006 - January 2006)
Chief Executive Officer @ Igeneon Ag (January 2004 - December 2005)
Chief Operations Officer @ Aphton (January 2005 - January 2005)
Chief Strategy Officer and Chief Executive Officer @ Cardion and Cardion Pharmaceuticals (January 1998 - January 2003)
PHD Student @ Max Planck Institute for Biophysical Chemistry Goettingen Germany (January 1991 - January 1994)
Diploma Student @ (January 1990 - January 1991)
Manfred Ruediger Education
University of Tübingen
Doctor of Philosophy (Molecular Biology, Biochemistry)
1985-1991
Manfred Ruediger Skills
Clinical Trials
Deal Sourcing
Hardware Diagnostics
Angel Investing
Start Ups
Technology Evaluation
Biotechnology
Cell
Regulatory Affairs
Immunology
Life Sciences
Medical Devices
Strategy
Licensing
Drug Discovery
Molecular Biology
Lifesciences
Entrepreneurship
Pharmaceuticals
Oncology
Drug Development
Clinical Development
Growth Capital
Vaccines
Cancer
Private Equity
Due Diligence
Pharmaceutical Industry
Biochemistry
Strategic Alliances
Corporate Development
Technology Transfer
Venture Capital
IPO
Mergers and Acquisitions
Patents
R&d
FDA
Commercialization
Venture Financing
Biopharmaceuticals
Research and Development R&d
Research and Development
Manfred Ruediger Summary
Manfred Ruediger, based in Germany, is currently a Chief Executive Officer at Ariceum Therapeutics. Manfred Ruediger brings experience from previous roles at Thermosome, 4SC AG, Minaris Regenerative Medicine GMBH and Medigene Ag. Manfred Ruediger holds a 1985 - 1991 Doctor of Philosophy in Molecular Biology, Biochemistry @ University of Tübingen. With a robust skill set that includes Clinical Trials, Deal Sourcing, Hardware Diagnostics, Angel Investing, Start Ups and more. Manfred Ruediger has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Manfred Ruediger?
Find contact details for 700 million professionals.